Literature DB >> 28966249

Bacterial Expression of a Single-Chain Variable Fragment (scFv) Antibody against Ganoderic Acid A: A Cost-Effective Approach for Quantitative Analysis Using the scFv-Based Enzyme-Linked Immunosorbent Assay.

Gorawit Yusakul1,2, Poomraphie Nuntawong3, Seiichi Sakamoto1, Pahweenvaj Ratnatilaka Na Bhuket3, Toshitaka Kohno1, Nao Kikkawa1, Pornchai Rojsitthisak3, Kuniyoshi Shimizu4, Hiroyuki Tanaka1, Satoshi Morimoto1.   

Abstract

Due to the highly specific binding between an antibody and its target, superior analytical performances was obtained by immunoassays for phytochemical analysis over conventional chromatographic techniques. Here, we describe a simple method for producing a functional single-chain variable fragment (scFv) antibody against ganoderic acid A (GAA), a pharmacologically active metabolite from Ganoderma lingzhi. The Escherichia coli BL21(DE3) strain produced a large amount of anti-GAA scFv. However, in vitro refolding steps, which partially recovered the reactivity of the scFv, were required. Interestingly, the functional scFv was expressed as a soluble and active form in the cytoplasm of an engineered E. coli SHuffle® strain. Purified anti-GAA scFv, which yielded 2.56 mg from 1 L of culture medium, was obtained from simple and inexpensive procedures for expression and purification. The anti-GAA scFv-based indirect competitive enzyme-linked immunosorbent assay (icELISA) exhibited high sensitivity (linearity: 0.078-1.25 µg/mL) with precision (CV: ≤6.20%) and reliability (recovery: 100.1-101.8%) for GAA determination. In summary, the approach described here is an inexpensive, simple, and efficient expression system that extends the application of anti-GAA scFv-based immunoassays. In addition, when in vitro refolding steps can be skipped, the cost and complexity of scFv antibody production can be minimized.

Entities:  

Keywords:  Escherichia coli; Ganoderma lingzhi; enzyme-linked immunosorbent assay; ganoderic acid A; single-chain variable fragment antibody

Mesh:

Substances:

Year:  2017        PMID: 28966249     DOI: 10.1248/bpb.b17-00531

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  5 in total

1.  Targeting c-Met on gastric cancer cells through a fully human fab antibody isolated from a large naive phage antibody library.

Authors:  Bahareh Zarei; Zahra Javidan; Elnaz Fatemi; Fatemeh Rahimi Jamnani; Shohreh Khatami; Vahid Khalaj
Journal:  Daru       Date:  2020-03-19       Impact factor: 3.117

2.  Plant-made antibody against miroestrol: a new platform for expression of full-length immunoglobulin G against small-molecule targets in immunoassays.

Authors:  Kaewta Rattanapisit; Tharita Kitisripanya; Atthaphon Konyanee; Worapol Sae-Foo; Apisit Burapapiruin; Waraporn Putalun; Seiichi Sakamoto; Waranyoo Phoolcharoen; Gorawit Yusakul
Journal:  Plant Cell Rep       Date:  2021-02-13       Impact factor: 4.570

3.  A Novel Full-length IgG Recombinant Antibody Highly Specific to Clothianidin and Its Application in Immunochromatographic Assay.

Authors:  Yunyun Chang; Yang Chen; Shasha Jiao; Xinying Lu; Yihua Fang; Yihua Liu; Ying Zhao; Xiuping Zhan; Guonian Zhu; Yirong Guo
Journal:  Biosensors (Basel)       Date:  2022-04-11

4.  A 33-residue peptide tag increases solubility and stability of Escherichia coli produced single-chain antibody fragments.

Authors:  Yang Wang; Wenjie Yuan; Siqi Guo; Qiqi Li; Xiaomei Chen; Cheng Li; Qianying Liu; Lei Sun; Zhenguo Chen; Zhenghong Yuan; Cheng Luo; Shijie Chen; Shuping Tong; Michael Nassal; Yu-Mei Wen; Yong-Xiang Wang
Journal:  Nat Commun       Date:  2022-08-08       Impact factor: 17.694

5.  Expression of actively soluble antigen-binding fragment (Fab) antibody and GFP fused Fab in the cytoplasm of the engineered Escherichia coli.

Authors:  Supaluk Krittanai; Waraporn Putalun; Seiichi Sakamoto; Hiroyuki Tanaka; Thaweesak Juengwatanatrakul; Gorawit Yusakul
Journal:  Mol Biol Rep       Date:  2020-05-11       Impact factor: 2.316

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.